This best PR is through the CDC and equivalent bodies in other countries. Opinion leaders in the field are listened to - glossy promotional material and other media strategies are usually a waste of money. Publications in medical journals are extremely valuable in building up a weight of evidence.
Use of the immunomodulating agents in treatment of autoimune diseases such as rheumatoid arthritis creates not an insignificant market when you are talking globally.
revised german guidelines., page-17
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
